期刊文献+

恩度诱导抑制性VEGFA选择性剪切异构体VEGF165b的表达及其意义 被引量:5

Inhibition effect of Endostar on angiogenesis partly through VEGF165b,the Inhibitory splice variant of VEGFA
原文传递
导出
摘要 目的:探讨重组人血管内皮抑制素(恩度)对人肝癌细胞SMMC-7721VEGF165b表达的影响,及上调VEGF165b表达后,SMMC-7721对恩度敏感性的变化。方法:采用RT-PCR法和蛋白质印迹法检测恩度干预SMMC-7721后VEGF165b的表达变化;稳定转染VEGF165b真核表达质粒到SMMC-7721,RT-PCR和免疫细胞荧光共聚焦显微镜检测VEGF165b、HIF-1α和下游靶基因VEGFA表达的变化;MTT法检测恩度对人肝癌细胞生长抑制率的影响。结果:100和400μg/mL恩度能够诱导VEGF165b mRNA和蛋白表达上调,而外源性VEGF165b下调HIF-1α及下游靶基因VEGFA的表达。转染空质粒后,500和1000μg/mL恩度引起SMMC-7721的生长移植率分别为1.6%和0.4%,转染VEGF165b后,500μg/mL和1000μg/mL恩度引起的生长移植率分别为8.5%(P=0.0000)和20.2%(P=0.0000)。结论:恩度抗肿瘤新生血管的作用部分是通过上调VEGF165b介导的,VEGF165b增加SMMC-7721细胞对恩度的敏感性,两者治疗肿瘤有协同作用。 OBJECTIVE:To investigate the impact of endostar on the expression of VEGF165b,and determine the effect of VEGF165b for he sensitivity of tumor cell to endostar. METHODS:The expression of VEGF165b of SMMC-7721 was detective by RT-PCR and Western Blotting after treated with endostar. After transfected with VEGF165b,the expression of HIF-1α and its downstream target genes VEGFA was analyzed by RT-PCR and Immunofluorescent confocal microscopy. SMMC-7721 cell was transfected with VEGF165b or empty vector,and then treated with endostar,the cell growth inhibiting rate was detected by methly thiazolyl tetrazolium (MTT). RESULTS:High dose endostar at 100 and 400 μg/mL up-regulated the expression of VEGF165b,while VEGF165b suppressed the expression of HIF-1α and its downstream target genes VEGFA. After transfection with empty-vector,treatment of SMMC-7721 cell with 500 and 1 000 μg/mL endostar induced the tumour cell growth inhibiting rate at 1.6% and 0.4% individually. After transfection with VEGF165b,treatment of SMMC-7721 cell with 500 and 1 000 μg/mL endostar induced the tumour cell growth inhibiting rate at 8.5% (P=0.000 0) and 20.2%( P=0.000 0) individually. CONCLUSIONS:Endostar can inhibite tumour growth and anti-angiogenisis partly via VEGF165b,and VEGF165b sensitize the tumour cell to endostar. VEGF165b and endostar have synergistic effect on tumor suppression.
出处 《中华肿瘤防治杂志》 CAS 2010年第1期37-40,49,共5页 Chinese Journal of Cancer Prevention and Treatment
关键词 内皮抑素类 血管内皮生长因子 肝肿瘤 endostatins vascular endothelial growth factor liver neoplasms
  • 相关文献

参考文献11

  • 1Folkman J. Tumor Angiogenesis[J]. Adv Cancer Res, 1985,43 : 175-203.
  • 2Roskoski R. Vascular endothelial growth factor (VEGF) signa ling in tumor progression[J]. Crit Rev Oncol Hematol, 2007, 62(3) : 179-213.
  • 3Ladomery M R, Harper S J, Bates D O. Alternative splicing in angiogenesis: The vascular endothelial growth factor paradigm [J]. Cancer Lett, 2007, 249(2):121-300.
  • 4Cui T G, Foster R R, Bates D O, et al. Differentiated human podoeytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF165b) mRNA and protein[J]. Am J Physiol Renal Physiol, 2004, 286(4) :F767-F773.
  • 5Bates D O, Cui T G, Harper SJ. VEGF165b, et al. An inhibitory splice variant of vascular endothelial growth factor, is down regulated in renal cell carcinoma[J]. Cancer Res, 2002, 62(14) : 4123-4131.
  • 6Varey A H, Rennel E S, Bates D O, et al. VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro and antiangiogenic VEGF-A isoforms has implications for therapy[J]. BrJ Cancer, 2008, 98(8):1366-1379.
  • 7Pritchard-Jones R, Dunn D B A, Bates D O, et al. Expression of VEGFxxxb, the inhibitory isoforms of VEGF, in malignant melanoma[J]. Br J Cancer, 2007, 97(2) :223-230.
  • 8Rennel E S, Hamdollah-Zadeh M A, Bates D O, et al. Recombinant human VEGF165b protein is an effective anti-cancer agent in mice[J]. Eur J Cancer, 2008, 44(13):1883-1894.
  • 9Rennel E, Waine E, Harper S, et al. The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice[J]. Br J Cancer, 2008, 98(7):1250-1257.
  • 10杨明智,陈汝福,陈积圣,毛伟征,张敬智.大肠肿瘤血管内皮生长因子的表达及其作用机制探讨[J].肿瘤防治杂志,2001,8(1):38-40. 被引量:1

二级参考文献9

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1367
  • 2Chen F,Castranova V,Shi X.New insights into the role of nuclear factor-kappaB in cell growth regulation[J].Am J Pathol,2001,159(2):387-397.
  • 3Hicklin D I,Ellis L M.Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis[J].J Clin Oncol,2005,23(5):1011-1027.
  • 4Weidner N.Current pathologic methods for measuring intratumoral microvessle density within breast carcinoma and other solid tumors[J].Breast Cancer Res Treat,1995,36(2):169-173.
  • 5Factor V,Oliver AL,Panta GR,et al.Roles of Akt/PKB and IKK complex in constitutive induction of NF-kappaB in hepatocellular carcinomas of transforming growth factor alpha/c-myc transgenic mice[J].Hepatology,2001,34 (1):32-41.
  • 6Takahashi M,Matsui A,Inao M,et al.ERK/MAPK-dependent PI3K/Akt phosphorylation through VEGFR-1 after VEGF stimulation in activated hepatic stellate cells[J].Hepatol Res,2003,26(3):232-236.
  • 7Li J,Zhang YP,Kirsner RS.Angiogenesis in wound repair:angiogenic growth factors and the extracellular matrix[J].Microsc Res Tech,2003,60(1):107-114.
  • 8Watanabe M,Dewan MZ,Okamura T,et al.A novel NF-kappaB inhibitor DHMEQ selectively targets constitutive NF-kappaB activity and induces apoptosis of multiple myeloma cells in vitro and in vivo[J].Int J Cancer,2005,114(1):32-38.
  • 9叶颖江,顾晋,祝学光,虞有志,于永详,曲军,冷希圣.肿瘤血管生成与结肠癌浸润转移的关系[J].中华实验外科杂志,1998,15(4):308-309. 被引量:5

共引文献11

同被引文献59

引证文献5

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部